Optic tract and internal capsule lesion in a patient with Wernicke-Korsakoff syndrome

  • Micaela Anahí Hernández Neurology department, FLENI, Buenos Aires, Argentina.
  • Francisco Varela Neurology department, FLENI, Buenos Aires, Argentina.
  • Catalina Bensi Neurology department, FLENI, Buenos Aires, Argentina.

Abstract

A 72-year-old man, presented with a one-week history of confusion and an anterograde amnesic disorder accompanied by confabulation, with lack of insight to his symptoms.

Medical history included alcohol abuse and admitted twenty-years of alcohol ingestion (approximately 186 gr/day).

Neurologic examination was notable for slightly decreased consciousness, disorientation to time, severe anterograde amnesia and unsteadiness of stance and gait with four limb ataxia.

A metabolic blood panel including liver profile showed alanine aminotransferase mildly elevated (66 UI/L) with elevated gamma-glutamyl-transpeptidase (gGT: 426 UI/L). Tests for HIV, syphilis and vitamin B12 levels were negative.

Review of initial brain MRI showed a symmetrical, increased fluid-attenuated inversion recovery (FLAIR) signal lesion extending through the hypothalamus, periaqueductal area, mamillary bodies, bilateral anterior thalami, chiasm, both optic tracts and posterior limbs of both internal capsules with restricted diffusion and patchy contrast enhancement (figure 1  1a-1b).

A possible Wernicke-Korsakoff syndrome diagnosis was achived. Following the initial examination, the patient was initiated on prophylactic parenteral thiamine reposition.

CSF analysis showed elevated proteins (174 mg/dl) and lactate concentration (2.9 mmol/L). Cytologic and immunocytochemical study showed no neoplastic processes. Screening of autoimmune antibodies in CSF and paraneoplastic antibodies in serum were negative.

EEG and full-body CT scans were unremarkable.

Thiamine serum levels were normal (16,5 ug/L) (blood sample collected previous to reposition). 

Finally, a neurocognitive test indicated malperformance in tasks related to immediate and delayed recall and disturbances in recent and remote memory with confabulation.

A new brain MRI after supplementation showed regression of the previous lesion (figure 1  2a-2b).

He was discharged one month later with residual anterograde amnesia and gait instability that are still present eleven months later, at the last follow up.

 

WKS_images.png

Figure 1:
(1) Axial FLAIR MRI sequence showing extensive, symmetrical, hyperintense lesion in chiasm and both optic tracts (1.a) and periaqueductal area, hypothalamus and posterior limb of internal capsules (1.b).
(2) Axial FLAIR MRI sequence showing regression of the hyperintense lesion one month after thiamine reposition in chiasm and both optic tracts (2.a) and periaqueductal area, hypothalamus and posterior limb of internal capsules (2.b)

 

Wernicke’s encephalopathy (WE) prototypical clinical triad consists of motor problems such as ataxia or gait incoordination, ocular signs (commonly ophthalmoparesis and nystagmus) and mental status changes1-3. Thiamine (vitamin B1) deficiency secondary to alcoholism is the most common etiologic factor3. If left untreated or undertreated, there is an increased risk of developing a chronic sequelae: the Korsakoff’s syndrome (KS), characterized with loss of working memory and confabulation with sparing of remote memories2-4. Both syndromes together are termed Wernicke-Korsakoff syndrome (WKS).

Even though diagnosis of WKS remains primarily clinical3, brain MRI findings in previously reported typical locations1-3are highly specific of this syndrome, suggesting MRI is a valuable confirmation tool.

Normal thiamine serum levels shouldn’t dismiss the initial suspicion, as its blood concentration does not necessarily reflect brain tissue’s concentration4.

Our case suggests that, even when MRI lesions are not characteristic, intravenous thiamine reposition should be immediately initiated if WKS is suspected, considering the patient's outcome depends on prompt diagnosis and adequate treatment.

Keywords: Wernicke’s encephalopathy, Wernicke-Korsakoff Syndrome, vitamin B1 deficiency

References

Isenberg-Grzeda E, Rahane S, DeRosa AP, Ellis J, Nicolson SE (2016). Wernicke-Korsakoff syndrome in patients with cancer: a systematic review. Lancet Oncol;17(4):e142–e148. doi: 10.1016/S1470-2045(16)00037-1

Sinha S, Kataria A, Kolla BP, Thusius N, Loukianova LL (2019). Wernicke Encephalopathy-Clinical Pearls. Mayo Clin Proc; 94(6):1065–1072. doi: 10.1016/j.mayocp.2019.02.018.

Sullivan EV, Pfefferbaum A (2009). Neuroimaging of the Wernicke-Korsakoff syndrome. Alcohol Alcohol; 44(2):155–165. doi: 10.1093/alcalc/agn103

Wicklund MR, Knopman DS (2013). Brain MRI findings in Wernicke encephalopathy. Neurol Clin Pract; 3(4):363‐364. doi: 10.1212/CPJ.0b013e3182a1ba00

Downloads

Download data is not yet available.
Published
2020-12-07
How to Cite
Hernández, M., Varela, F., & Bensi, C. (2020). Optic tract and internal capsule lesion in a patient with Wernicke-Korsakoff syndrome. Journal of Applied Cognitive Neuroscience, 1(1), 118-120. Retrieved from https://revistascientificas.cuc.edu.co/JACN/article/view/3341